LEXX
LEXX
NASDAQ · Pharmaceuticals

Lexaria Bioscience Corp

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$0.77
-0.02 (-2.05%)
As of Mar 25, 5:21 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,350.4% upside
Low Target $20.55
Average Target $26.43
High Target $40.48
Current Price $0.77
Current
$0.77
Target
$26.43
$20.55 $26.43 avg $40.48
Scenario Analysis
Bear Case
$20.55
2,582.8%
Low target
Base Case
$26.43
+3,350.4%
Avg target
Bull Case
$40.48
+5,184.6%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$1.90
-59.6% from high
52-Week Low
$0.46
+66.5% from low
Target vs 52W High
$26.43
+1,294.4% vs high
Next Earnings Report
Apr 13, 2026
17d
until earnings
EPS Est: $-0.10
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%